Triple-negative breast cancer (TNBC) is a subtype of breast cancer distinguished by negative expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, comprising approximately 15–20% of all breast cancer cases (1). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.